Procter & Gamble Health Ltd Share Price

Pharmaceuticals - Multinational

NSE: PGHL Small Cap ISIN: INE199A01012

As on 22 January 2025 at 18:36 IST

₹5,408.15

-75.90

(-1.38%)

Sell Buy

Over 1 Month

1.05%

Over 6 Months

7.03%

Over 1 Year

4.79%

Over 3 Years

7.66%

Procter & Gamble Health Ltd Summary

Close ₹ 5,408.15

Open ₹ 5,480

High ₹ 5,480

Low ₹ 5,313.20

Volume 3,110

Net Turnover (in ₹) ₹ 3,41,77,306.10

52Wk High ₹ 5,850

52Wk Low ₹ 4,636.55

52Wk High / Low

4,636.55

5,850

Procter & Gamble Health Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 9,103.18

EPS (TTM) 136.52

Book Value (BV) 324.25

Div. Yield 4.73 %

P/E (TTM) 41.92

Price/Book Value 16.96

Delivery % 57.69 %

Face Value 10

Key Ratios

PE Ratio 41.71

PB Ratio 15.57

EV to Sales 7.08

PEG Ratio -3.36

ROA 34.76

ROE 31.18

Debt-Equity 0.02

Net Profit Margin 17.46

Operating Profit Margin 26.18

Procter & Gamble Health Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,166.89	1,248.01	1,127.60	1,026.83	1,424.75
Total Expenses	873.38	933.81	874.23	793.55	1,069.90
Profit Before Tax	273.32	314.20	253.37	233.28	354.85
Profit After Tax	200.98	229.47	192.52	176.80	254.08
Operating Profit after Depreciation	294.23	314.97	253.79	234.08	354.85

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	126.60	141.72	109.06	100.96	97.92
Total Non Current Assets	270.14	305.09	280.08	259.02	222.18
Total Current Assets	524.22	796.10	608.04	727.14	953.56
TOTAL ASSETS	794.36	1,101.19	888.12	986.16	1,175.74
Total Shareholder's Fund	538.24	750.89	616.49	703.71	906.34

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	228.28	236.01	169.52	247.26	235.37
Net Cash used in Investing Activities	-6.87	-21.50	-25.54	-32.27	164.64
Net Cash used in Financing Activities	-418.10	-98.49	-288.63	-386.63	-883.41

No data available

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	313.41	283.88	252.48	309.97	304.93
Total Expenses	199.37	235.63	185.04	208.32	216.27
Profit Before Tax	111.40	22.83	62.72	99.72	88.05
Profit After Tax	82.33	16.78	46.56	72.07	65.57
Operating Profit after Depreciation	117.32	50.38	69.71	106.83	94.71

Procter & Gamble Health Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 5,412.15

S2 5,340.25

S3 5,255.50

Pivot 5,496.90

R1 5,568.80

R2 5,653.55

R3 5,725.45

Moving Average

20 SMA 5,276.06

50 SMA 5,338.34

100 SMA 5,299.52

200 SMA 5,140.74

Procter & Gamble Health Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Procter & Gamble Health Ltd

₹60/Share

Announcement Date 28 Nov 2024

Record Date 29 Nov 2024

Div Yield 600%

AGM Date: 23 Nov 2022

AGM 23/11/2022 We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige. (As Per BSE Announcement Dated on 31.10.2022) We would like to inform you that the 55th Annual General Meeting of the Company was held today, November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed a summary of proceedings of the 55th Annual General Meeting. Further, we have enclosed copy of presentation on business review and overview on Corporate Social Responsibility activities of the Company presented at the 55th Annual General Meeting held today, i.e., November 23, 2022. (As per BSE Announcement Dated on 23/11/2022) We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige. We are pleased to informed that the Shareholders of the Company have at their Annual General Meeting held on November 23, 2022, approved re-appointment of M/s. Haribhakti & Co. LLP, Chartered Accountants, as the Statutory Auditors for a second term of 5 (five) years ie. to hold office from the conclusion of this 55th Annual General Meeting upto the conclusion of 60th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 24/11/2022)

AGM Date: 30 Nov 2023

AGM 21/11/2023 We would like to inform you that the 56th Annual General Meeting( AGM) of the Company is to be held on Thursday, November 30,2023. The register of members and share transfer books shall remain closed from Friday, November 24,2023 to Thursday, November 30,2023 for the purpose of the AGM and payment of dividend for the year ended June 30,2023. (As per BSE Announcement Dated on 20/10/2023) AGM 30/11/2023 (Revised) (As Per BSE Bulletin Dated on 25.10.2023) We would like to inform you that the 56th Annual General Meeting of the Company was held on November 30,2023 at 3:30 p.m. through video conference/ other audio visual means. Find enclosed a copy of presentation on business review of the Company as presented at the 56th Annual General Meeting. We would like to inform you that the 56th Annual General Meeting was held on November 30,2023 at 3:33 p.m. In this respect find enclosed the voting result and scrutinizers report. Find enclosed the scrutinizers'' report on the voting and remote evoting with respect to the 56th AGM held on November 30,2023. (As per BSE Announcement Dated on 01/12/2023)

AGM Date: 05 Dec 2024

We would like to inform that the Register of Members and Share transfer books shall remain closed from November 29, 2024 to December 5, 2024 for the purpose of Annual General Meeting and payment of dividend for the Financial Year 2023-24, if approved by the shareholders of the Company at their 57th Annual General Meeting to be held on December 5, 2024. The notice of the Annual General Meeting will be shared in the due course. Dear Sir, Please find the proceedings of the 57th Annual General meeting held on December 5, 2024. (As per BSE Announcement Dated on 05/12/2024)

Procter & Gamble Health Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Procter & Gamble Health Ltd	₹5,498	₹9,126.34
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Procter & Gamble Health Ltd News

Procter & Gamble Health announces board meeting date

On 12 February 2025

28 Dec 2024, 09:36 am

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Procter & Gamble Health rallied 7.17% to Rs 5,657.75 after the company's net profit jumped 25.56% to Rs 82.33 crore on 2.78% rise in revenue from operations to Rs 313.41 crore in Q2 FY25 over Q2 FY24.

05 Nov 2024, 09:59 am

Procter & Gamble Health to hold board meeting

On 4 November 2024

28 Sep 2024, 10:06 am

Procter & Gamble Health schedules AGM

On 5 December 2024

23 Aug 2024, 11:48 am

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Procter & Gamble Health slipped 3.04% to Rs 5199.50 after the pharma company's net profit tumbled 43.73 % to Rs 16.78 crore in Q4 June 2024 as against Rs 29.82 crore recorded in Q4 June 2023.

22 Aug 2024, 10:02 am

Procter & Gamble Health Ltd Stock Analysis

Annual revenue for Procter & Gamble Health Ltd remains unchanged by 0.00% to ₹0 crore in FY 2024 from ₹0 crore in FY 2023.
Annual Net Profit for Procter & Gamble Health Ltd remains unchanged by 0.00% to ₹0 crore in FY 2024 from ₹0 crore in FY 2023.
Promoter Shareholding in Procter & Gamble Health Ltd remains unchanged by 0.00% in the most recent quarter, from 51.82% in September 2024 to 51.82% in December 2024.
Procter & Gamble Health Ltd delivered a 1-year return of 4.79% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Procter & Gamble Health Ltd share price moved down by 1.38% from its previous close of INR ₹5,484.05. The latest Procter & Gamble Health Ltd share price is INR ₹5,408.15.
Procter & Gamble Health Ltd share price today has been at a low of 5,313.20 and a high of 5,480. Over the past 52 weeks, the Procter & Gamble Health Ltd share price has seen a low of 4,636.55 and a high of 5,850.